Seoul National University Hospital launches Eurostar project… Heart failure diagnosis device development
Reporter Jung Eun-ha
Approval 2017.07.21 16:06
Opinion
0
Seoul National University Hospital has begun developing an in vitro diagnostic device that predicts the risk of heart failure with the winning of the Eurostar project, an international research project for industry-university cooperation. Eurostar is a multinational industry-academic research project in which European and non-European medical institutions and industries jointly form a consortium.
According to Seoul National University Hospital on the 21st, this hospital was hosted by Korean bio-venture Quantametrics, European bio-company Piralis (France), Simplicity Bio (Switzerland) and Toulouse University Hospital (France). It launched a consortium and launched the Eurostar project for Korea-EU international joint research last month.
An official from Seoul National University Hospital said, “With this HeartLinc consortium, we have received a grant of 3.2 million euros (about 4.2 billion won) and developed an in vitro diagnostic device that predicts the risk of heart failure after acute myocardial infarction.” It will go on for a year,” he said.
Acute myocardial infarction, which is one of the leading causes of death in the world, is mainly due to the occurrence of heart failure. It is known that 30% of patients with acute myocardial infarction develop heart failure within 5 years. Of these, 60% die within 5 years of diagnosis. Heart failure is the main cause of sudden death, and the increase in heart failure patients due to aging is also pointed out as a burden of national medical expenses. According to the Ministry of Welfare, Korea estimates that by 2030, 25% of the elderly population will be patients with heart failure.
Early diagnosis is essential to slow down the progression of heart failure. However, until now, diagnostic methods to predict heart failure in the early onset of myocardial infarction have not been adequate. An official at Seoul National University Hospital said, “Through this study, it is expected that we will be able to know the progression of heart failure in advance.”
Lee Hae-young, professor of cardiovascular medicine at Seoul National University Hospital, said, “This research has an important meaning that domestic medical institutions have been taking the lead in international projects with industry.” It is expected to improve the treatment performance of the patient.”
Copyright holder ⓒ Saturday Economy, unauthorized reproduction and redistribution prohibited